No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
1 Reason to Sell DexCom Stock, and 1 Reason to Buy
Benzinga Market Summary: S&P Rises On PCE Data, Novo Nordisk Falls On Weight Loss Data, Diabetes Stocks Rise
DexCom, Insulet, Tandem Benefit From Novo Nordisk CagriSema Data
Shares of Glucose Monitoring Stocks Are Trading Higher Following Weaker-than-expected Weight Loss Data From Novo Nordisk.
Oura Raises $200M With Investment From Dexcom
Oura Boosts Valuation to $5.2B in Latest Funding Round
Unlock the Full List